Antifungal therapy in special situations: resistant candidiasis and aspergillosis
Rabagliati, R.
Drugs of Today 46 Suppl C: 27-32
2010
ISSN/ISBN: 1699-3993 PMID: 20490380 Document Number: 642007
Fungal infections are an increasingly frequent problem in oncohematological patients with febrile neutropenia and hematopoietic precursors transplant recipients. According to the definitions of the EORTC/MSG Consensus Group, the term invasive fungal infection (IFI) is preferred nowadays to name this group of infections. This aims at highlighting the complex disease resulting from a fungal infection involving higher morbidity, longer hospital stays, increased health care costs and higher mortality risk. Candidiasis and aspergillosis account for about 80% of IFIs in oncohematological patients, while Fusarium diseases, mucormycosis, among others, are emerging infections.